BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17889451)

  • 21. Toward comprehensive studies of HIV in intravenous drug users: issues in treatment-based and street-based samples.
    Watters JK; Cheng YT
    NIDA Res Monogr; 1991; 109():63-73. PubMed ID: 1753992
    [No Abstract]   [Full Text] [Related]  

  • 22. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 23. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R; Karimi A; Rouzbahani R; Rouzbahani A
    East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse.
    Kumar MS; Virk HK; Chaudhuri A; Mittal A; Lewis G
    Int J Drug Policy; 2008 Apr; 19(2):148-58. PubMed ID: 18221862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once more unto the breach: controlling hepatitis C in injecting drug users.
    Wodak A; Crofts N
    Addiction; 1996 Feb; 91(2):181-4. PubMed ID: 8835275
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV prevention and psychoactive drug use: a research agenda.
    Des Jarlais DC; Semaan S
    J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Knowledge about hepatitis B and C viruses and HIV among blood donors in Casablanca].
    Boutayeb H; Aamoum A; Benchemsi N
    East Mediterr Health J; 2006 Sep; 12(5):538-47. PubMed ID: 17333791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 30. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 31. Impending concentrated HIV epidemic among injecting drug users in Central Bangladesh.
    Azim T; Alam MS; Rahman M; Sarker MS; Ahmed G; Khan MR; Rahman S; Rahman AS; Sack DA
    Int J STD AIDS; 2004 Apr; 15(4):280-2. PubMed ID: 15075028
    [No Abstract]   [Full Text] [Related]  

  • 32. Interventions with injection drug users in Ukraine.
    Booth RE; Lehman WE; Dvoryak S; Brewster JT; Sinitsyna L
    Addiction; 2009 Nov; 104(11):1864-73. PubMed ID: 19681800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV risk behaviors of heterosexual male drug users.
    Needle RH
    NIDA Res Monogr; 1994; 143():5-8. PubMed ID: 8742587
    [No Abstract]   [Full Text] [Related]  

  • 34. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing HIV transmission in intravenous-drug users not in drug treatment--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Aug; 39(31):529, 535-8. PubMed ID: 2115973
    [No Abstract]   [Full Text] [Related]  

  • 36. Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study.
    Mackesy-Amiti ME; Finnegan L; Ouellet LJ; Golub ET; Hagan H; Hudson SM; Latka MH; Garfein RS
    AIDS Behav; 2013 Jul; 17(6):2075-83. PubMed ID: 23142857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of the NGO-based relational intervention model for HIV prevention among drug users in China.
    Chen HT; Liao Q
    AIDS Educ Prev; 2005 Dec; 17(6):503-14. PubMed ID: 16398573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can HIV epidemics among injection drug users be prevented?
    Strathdee SA; van Ameijden EJ; Mesquita F; Wodak A; Rana S; Vlahov D
    AIDS; 1998; 12 Suppl A():S71-9. PubMed ID: 9632987
    [No Abstract]   [Full Text] [Related]  

  • 39. A new role for pediatric nurses: teaching teen drug users how to sterilize their equipment for prevention of infectious disease; a course outline.
    Edwards K
    Pediatr Nurs; 2006; 32(3):257-62. PubMed ID: 16802685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in needle sharing behaviour patterns.
    Smyth B; Keenan E; Dorman A; O'Connor JJ
    Addiction; 1994 Jan; 89(1):96-7. PubMed ID: 8148751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.